HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Jil

This article was originally published in The Rose Sheet

Executive Summary

Jil: Women's fragrance bowing exclusively in 50 Saks Fifth Avenue doors and three Jil Sander stores in September, U.S. distributor Gary Farn said. The scent will eventually roll-out to the designer's full distribution of 85 department store doors. The "aromatic, woody oriental" opens with top notes of lavender, raspberry and fresh herbs, leading to a heart of cedar woods, vetiver, iris and violet accords. The drydown consists of vanilla. Jil is a "lighter, kickier" scent than Jil Sander No. 4, Garn Farn said. Other offerings by the designer include Woman III, Sun and Bath & Beauty Pure. The Jil line includes a 1.7 eau de toilette spray for $50, a 3.4 oz. edt spray for $75 and a .5 oz. parfum for $125. Three bath items -- body lotion, shower gel and body cream -- will roll out in November...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel